IL320766A - שיטות לייצור פוליפפטידים מאוחים - Google Patents
שיטות לייצור פוליפפטידים מאוחיםInfo
- Publication number
- IL320766A IL320766A IL320766A IL32076625A IL320766A IL 320766 A IL320766 A IL 320766A IL 320766 A IL320766 A IL 320766A IL 32076625 A IL32076625 A IL 32076625A IL 320766 A IL320766 A IL 320766A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- fusion polypeptides
- making fusion
- making
- polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5434—IL-12
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/11—Protein-serine/threonine kinases (2.7.11)
- C12Y207/11001—Non-specific serine/threonine protein kinase (2.7.11.1), i.e. casein kinase or checkpoint kinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263424047P | 2022-11-09 | 2022-11-09 | |
| PCT/US2023/037011 WO2024102400A2 (en) | 2022-11-09 | 2023-11-08 | Methods of making fusion polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL320766A true IL320766A (he) | 2025-07-01 |
Family
ID=89164434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL320766A IL320766A (he) | 2022-11-09 | 2025-05-07 | שיטות לייצור פוליפפטידים מאוחים |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4615976A2 (he) |
| JP (1) | JP2025540624A (he) |
| KR (1) | KR20250122543A (he) |
| CN (1) | CN120500541A (he) |
| AU (1) | AU2023376942A1 (he) |
| IL (1) | IL320766A (he) |
| MX (1) | MX2025005424A (he) |
| WO (1) | WO2024102400A2 (he) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11642409B2 (en) * | 2019-06-26 | 2023-05-09 | Massachusetts Insttute of Technology | Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof |
| AU2022269602A1 (en) * | 2021-05-05 | 2023-11-09 | Ankyra Therapeutics, Inc. | Fusion polypeptides |
-
2023
- 2023-11-08 JP JP2025526768A patent/JP2025540624A/ja active Pending
- 2023-11-08 AU AU2023376942A patent/AU2023376942A1/en active Pending
- 2023-11-08 CN CN202380087063.2A patent/CN120500541A/zh active Pending
- 2023-11-08 EP EP23821408.4A patent/EP4615976A2/en active Pending
- 2023-11-08 WO PCT/US2023/037011 patent/WO2024102400A2/en not_active Ceased
- 2023-11-08 KR KR1020257018590A patent/KR20250122543A/ko active Pending
-
2025
- 2025-05-07 IL IL320766A patent/IL320766A/he unknown
- 2025-05-08 MX MX2025005424A patent/MX2025005424A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2025005424A (es) | 2025-07-01 |
| WO2024102400A2 (en) | 2024-05-16 |
| KR20250122543A (ko) | 2025-08-13 |
| AU2023376942A1 (en) | 2025-05-15 |
| CN120500541A (zh) | 2025-08-15 |
| JP2025540624A (ja) | 2025-12-16 |
| EP4615976A2 (en) | 2025-09-17 |
| WO2024102400A3 (en) | 2024-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286745A (he) | ייצור רציף של חלבונים רקומבינטים | |
| IL308240A (he) | פוליפפטידים מאוחים | |
| SG11202012582QA (en) | Methods of producing recombinant proteins | |
| GB202113559D0 (en) | Fusion polypeptide | |
| GB201902908D0 (en) | Method of using a blockchain | |
| IL316697A (he) | חלבוני איחוי cd200 חדשים | |
| IL317645A (he) | שיטות להכנת טולברוטיניב | |
| IL320770A (he) | שיטות לייצור פוליפפטידים מאוחים | |
| IL314282A (he) | פוליפפטידים כימריים | |
| EP4294422A4 (en) | ANTI-PATHOGEN INTERLEUKIN-TGF-BETA RECEPTOR FUSION POLYPEPTIDES | |
| HK40128691A (zh) | 一种制备融合多肽的方法 | |
| CA3273017A1 (en) | Methods of making fusion polypeptides | |
| HK40128690A (en) | Methods of making fusion polypeptides | |
| GB201913804D0 (en) | Fusion polypeptides | |
| GB202315671D0 (en) | Polypeptides | |
| GB202105044D0 (en) | Fusion protein | |
| GB202219576D0 (en) | Polypeptides | |
| IL317593A (he) | חלבוני איחוי פוליסטטין-fc | |
| GB202218084D0 (en) | Fusion proteins | |
| GB202217084D0 (en) | Therapeutic fusion proteins | |
| GB202402535D0 (en) | Fusion proteins | |
| CA3292598A1 (en) | Antagonist fusion polypeptides | |
| AU2024277146A1 (en) | Antagonist fusion polypeptides | |
| IL317203A (he) | מינון חלבון איחוי קושר-cd38 | |
| IL318371A (he) | מעכבים של klk5 חלבונים מאוחים |